The Drug Enforcement Administration (DEA) has denied testimony from key witnesses ahead of scheduled hearings to discuss the potential classification of two psychedelic compounds, ...
The Drug Enforcement Administration has rejected witnesses and testimony from the group fighting to keep two psychedelic compounds out of Schedule I. The agency has a meeting scheduled in November to ...
A classic psychedelic, similar to LSD, psilocybin and mescalin, was found to activate a cell type in the brain that silences other neighboring neurons, a result that provides insight into how such ...